OA
DXCM icon

Oracle Alpha’s DexCom DXCM Stock Holding History

Oracle Alpha’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		$266K Sell
1,915
-860
-31% -$108K 0.48% 99
2023
Q4 		$344K Buy
+2,775
New +$283K 0.45% 81

Other funds holding DXCM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Oracle Alpha's DXCM Position: Q1 2024 in Review

Oracle Alpha reduced its DexCom (DXCM) stake by 31% in Q1 2024, selling an estimated $108K and leaving 1,915 shares worth $266K. The position accounts for 0.48% of the portfolio, ranked #99.

Oracle Alpha first reported a position in DXCM in Q4 2023 and has held it in 2 quarters since. The position peaked at $344K in Q4 2023. 1,033 funds tracked by Wall St. Rank hold DXCM as of Q1 2024.

  • Oracle Alpha held 1,915 shares of DexCom worth $266K as of Q1 2024.
  • Oracle Alpha sold 860 DexCom shares in Q1 2024, an estimated $108K.
  • DexCom made up 0.48% of Oracle Alpha's portfolio in Q1 2024, its #99 holding.
  • Oracle Alpha first reported a position in DexCom in Q4 2023 and has held it in 2 quarters since.
  • Oracle Alpha's DexCom position peaked at $344K in Q4 2023.
  • 1,033 funds tracked by Wall St. Rank held DexCom as of Q1 2024.

Based on Oracle Alpha's 13F filing for Q1 2024, filed 15 May 2024.